At Bristol Myers Squibb, patients are at the center of everything we do. When employees are asked what motivates them, the answer is always the same: We work together for patients.



Our Representatives

Heather Pound

CAR T Medical Science ..., Bristol Myers Squibb

CAR T Medical Science Liasion

Bristol Myers Squibb

Laurie Connor

AD IME Hematology-LYM, Bristol Myers Squibb

AD IME Hematology-LYM

Bristol Myers Squibb

I am the lead for Lymphoma and Lymphoma CAR-T Independent Medical Education.

Melissa Thebeau

Senior MSL, Hematology, Bristol Myers Squibb

Senior MSL, Hematology

Bristol Myers Squibb

REBLOZYL is a prescription medicine used to treat anemia (low red blood cells) in adults with myelodysplastic syndromes with ring sideroblasts (MDS‑RS) or myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN‑RS‑T) who need regular RBC transfusions and have not responded well to or cannot receive an erythropoiesis stimulating agent (ESA).

REBLOZYL is not for use as a substitute for RBC transfusions in people who need immediate treatment for anemia.

It is not known if REBLOZYL is safe or effective in children.